Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2002 | 01-2002 | 10-2001 | 07-2001 | 04-2001 | |
| Sales | 298,300 | 293,500 | 391,600 | 547,500 | 652,400 |
| Cost of Goods | 224,600 | 198,700 | 277,400 | 369,800 | 530,100 |
| Gross Profit | 73,700 | 94,800 | 114,200 | 177,700 | 122,300 |
| Operating Expenses | 234,800 | 160,900 | 340,200 | 277,000 | 816,600 |
| Operating Income | -160,500 | -65,400 | -225,600 | -98,500 | -694,200 |
| Other Income | 27,500 | -4,500 | -138,500 | 11,700 | -765,000 |
| Pre-tax Income | -133,000 | -69,900 | -364,100 | -86,800 | -1,459,200 |
| Income Tax | -43,800 | -25,100 | -187,300 | -28,700 | -414,000 |
| Net Income Continuous | -89,200 | -44,800 | -176,800 | -58,100 | -1,045,200 |
| Net Income | $-89,200 | $-44,800 | $-176,800 | $-58,100 | $-1,045,200 |
| EPS Basic Total Ops | -0.77 | -0.42 | -1.61 | -0.49 | -9.31 |
| EPS Basic Continuous Ops | -0.79 | -0.40 | -1.56 | -0.52 | -9.31 |
| EPS Diluted Total Ops | -0.77 | -0.42 | -1.61 | -0.49 | -9.31 |
| EPS Diluted Continuous Ops | -0.79 | -0.40 | -1.56 | -0.52 | -9.31 |
| EBITDA(a) | $-130,200 | $-157,400 | $-131,800 | $444,900 | $-638,500 |